What does this research mean for the field?

First-line diagnostic tests such as HPLC and hemogram data reliably characterize most sickle cell disorders in a hospital setting, while molecular analysis is essential for complex cases and resolving diagnostic discrepancies. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

March 4, 20261 citations

Utility of First-Line Diagnostic Tests and Molecular Methods for Accurate Characterization of Sickle Cell Disorders.

View Full Paper

DYDiksha Dev YadavArtemis Hospitals SCSanjeev ChhabraPost Graduate Institute of Medical Education and Research JHJasbir Kaur HiraPost Graduate Institute of Medical Education and Research

Key Points

The focus is on determining the reliability of diagnostic tests and molecular methods for accurate characterization of sickle cell disorders (SCDs).
Analysis of HPLC and hemogram data for sickle cell diagnosis
Use of the sickling test to support clinical findings
Inclusion of parental HPLCs for complex cases
Evaluation of molecular analysis for diagnostic accuracy
HPLC and hemogram data reliably characterize most SCDs
Sickling test supplements traditional diagnostic methods
Molecular analysis improves resolution of complex cases
Sensitivity to the limitations of each diagnostic method is essential

Abstract

Most SCDs encountered in a hospital-setting are reliably characterized by HPLC and hemogram data, supplemented with the sickling test and, where necessary, parental HPLCs. Molecular analysis aids in accurate characterization of complex cases and in resolution of diagnostic discrepancies; however, their own pitfalls must be borne in mind.

Demander à l'IA

Bookmark

View Full Paper

Demander à l'IA

Bookmark

View Full Paper

Utility of First-Line Diagnostic Tests and Molecular Methods for Accurate Characterization of Sickle Cell Disorders.

Key Points

Abstract

Cite This Study